Mir-Coll, J.; Moede, T.; Paschen, M.; Neelakandhan, A.; Valladolid-Acebes, I.; Leibiger, B.; Biernath, A.; Ämmälä, C.; Leibiger, I.B.; Yesildag, B.;
et al. Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes. Int. J. Mol. Sci. 2021, 22, 1813.
https://doi.org/10.3390/ijms22041813
AMA Style
Mir-Coll J, Moede T, Paschen M, Neelakandhan A, Valladolid-Acebes I, Leibiger B, Biernath A, Ämmälä C, Leibiger IB, Yesildag B,
et al. Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes. International Journal of Molecular Sciences. 2021; 22(4):1813.
https://doi.org/10.3390/ijms22041813
Chicago/Turabian Style
Mir-Coll, Joan, Tilo Moede, Meike Paschen, Aparna Neelakandhan, Ismael Valladolid-Acebes, Barbara Leibiger, Adelinn Biernath, Carina Ämmälä, Ingo B. Leibiger, Burcak Yesildag,
and et al. 2021. "Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes" International Journal of Molecular Sciences 22, no. 4: 1813.
https://doi.org/10.3390/ijms22041813
APA Style
Mir-Coll, J., Moede, T., Paschen, M., Neelakandhan, A., Valladolid-Acebes, I., Leibiger, B., Biernath, A., Ämmälä, C., Leibiger, I. B., Yesildag, B., & Berggren, P.-O.
(2021). Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes. International Journal of Molecular Sciences, 22(4), 1813.
https://doi.org/10.3390/ijms22041813